The Rise and Rise of Prefillable Syringes

Jul 1, 2014

Prefillable syringes are fuelling one of the medical device industry`s fastest growing and most innovative markets. Cecilia Stroe, Managing Editor of IPI, takes you inside one of the most modern production facilities for ready-to-fill syringe systems and cartridges in the world. The plant is operated by Gerresheimer Group, a leading partner to the pharma and healthcare industry. ...

Read More

Cleanroom Injection Moulding

Jul 1, 2014

Demand for cleanroom conditions in injection moulding packaging processes has expanded almost exponentially in recent years, as growing numbers of medical and pharmaceutical manufacturers come to rely on the technology to meet the manufacturing requirements of the European Medical Devices Directive. As a result, shows Stewart Gordon-Smith of Meech International, it is becoming increasingly important that professionals in the medical and pharmaceutical industries have at least a basic understanding of the most important elements of cleanroom injection moulding, as well as how to avoid potential pitfalls. ...

Read More

How to Eliminate Cleaning and Be Rewarded with Substantially Improved OEE

Jul 1, 2014

“Tumbling” is a widely-used way of dry powder blending in the oral solid dosage (OSD) manufacturing environment. In his article, Wim Spook of Matcon demonstrates how IBC blenders, when compared with other methods of dry powder blending, can significantly increase your blending capacity and reduce your manufacturing costs. ...

Read More

Novel Treatment to Help Fight Drug-resistant Bacteria

Jul 1, 2014

MRSA poses a significant public health problem around the world, yet our approach to treating infections is currently fuelling a wider issue around antibiotic resistance. In this article, Dr Paul De Bank explores how a new type of wound dressing, developed by researchers at the University of Bath, could help in the fight against superbugs. ...

Read More

Maintaining Integrity of the Supply Chain

Jul 1, 2014

For the pharmaceutical industry, the prevalence of counterfeit drugs can represent loss of reputation, loss of valuable R&D efforts and intellectual property, loss of revenue, and increased costs. Sue Lee of World Courier asks what can pharmaceutical professionals do to ensure that their organisations and the patients they serve are not impacted by counterfeit drugs? The answer is to identify their highest risk products and shipments and to secure their supply chain to the fullest extent possible. ...

Read More